Journal of Leukemia
Open Access

Identification of the Disease Bone Marrow Aspiration and its Clinical Application in Leukaemia Treatment

Michael Anderson^{* *}Correspondence: Michael Anderson, Department of Hematology, University of Alberta, Edmonton, Canada, Email:

Author info »

Description

Bone marrow aspiration is a critical procedure in the diagnosis and management of leukemia, a type of cancer that affects bloodforming tissues, primarily the bone marrow. This procedure involves extracting a sample of bone marrow, which is the soft tissue inside bones responsible for producing blood cells. The analysis of this sample is importance for diagnosing leukemia, determining its type, assessing its progression, and guiding treatment decisions. Leukemia is classified into four main types: Acute Lymphoblastic Leukemia (ALL), Acute Myeloid Leukemia (AML), Chronic Lymphocytic Leukemia (CLL), and Chronic Myeloid Leukemia (CML). Each type has distinct characteristics, risk factors, and treatment approaches.

The primary purpose of bone marrow aspiration in leukemia is to confirm the diagnosis. The procedure enables healthcare professionals to obtain a sample of bone marrow, which is examined for the presence of abnormal cells, helping to identify the specific type of leukemia. Determining the stage of leukemia is essential for prognosis and treatment planning. Bone marrow aspiration helps assess the extent of disease involvement in the bone marrow, providing critical information about the stage of leukemia. Bone marrow aspiration is used to evaluate how well a patient is responding to treatment. By comparing pre and posttreatment samples, healthcare providers can assess the effectiveness of therapies and make necessary adjustments. Regular bone marrow aspirations may be necessary for patients in remission to detect any signs of relapse. Early identification of relapse can lead to prompt intervention and better outcomes.

Before undergoing a bone marrow aspiration, the patient is typically informed about the procedure's purpose and what to expect. Healthcare providers review the patient's medical history, including any previous blood disorders or treatments. The patient is positioned comfortably, usually lying on their side or back, to allow easy access to the bone. Site Selection is the most common sites for aspiration are the posterior iliac crest (hip bone) and the sternum (breastbone). The choice of site depends on the patient's age, body habitus, and the specific clinical situation. Local anesthesia is administered to numb the area ere the needle will be inserted. Sedation may be offered for patients who are anxious. A special aspiration needle is inserted into the selected site. The healthcare provider carefully advances the needle into the bone marrow space. Once the needle is in place, the provider applies suction to draw out a small amount of bone marrow. This sample is collected in a syringe for laboratory analysis. Post-procedure care after the sample is collected, the needle is removed, and pressure is applied to the site to minimize bleeding. The area may be bandaged, and patients are advised on post-procedure care.

Some patients may experience mild to moderate pain at the aspiration site during and after the procedure. There is a risk of bleeding, especially in patients with low platelet counts. Although rare, there is a risk of infection at the needle insertion site. Patients may have allergic reactions to local anesthetics or other medications used during the procedure. Once the bone marrow sample is obtained, it undergoes a series of laboratory analyses; cytological examination is the sample is examined under a microscope to identify the presence of abnormal cells. Cytopathologists assess the morphology of cells, looking for characteristics that indicate leukemia.

This technique is used to analyze the types of cells in the sample based on their surface markers. It helps determine the specific type of leukemia and can provide prognostic information. Chromosomal abnormalities are assessed to identify specific genetic changes associated with different leukemia types. This information can guide treatment decisions and predict outcomes. Molecular assays may be performed to detect specific mutations or genetic markers that can influence treatment options and prognosis. The most common treatment for leukemia, chemotherapy involves using drugs to kill cancer cells or inhibit their growth. Certain types of leukemia, such as CML, may respond well to targeted therapies that specifically inhibit the activity of mutated genes involved in cancer growth. In some cases, particularly for aggressive leukemias or those that do not respond to chemotherapy, a stem cell transplant may be considered to restore healthy blood cell production. Emerging treatments, such as CAR T-cell therapy, harness the patient’s immune system to target and destroy leukemia cells.